Inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn: when is it enough?
Jankov
Robert P
RP
Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada M5G 1X8. robert.jankov@sw.ca
McNamara
Patrick J
PJ
D015199:Extracorporeal Membrane Oxygenation; D006801:Humans; D007231:Infant, Newborn; D009569:Nitric Oxide / Q000627:therapeutic use*; D010547:Persistent Fetal Circulation Syndrome / Q000150:complications*; D012127:Respiratory Distress Syndrome, Newborn / Q000209:etiology* / Q000628:therapy*
D009569:Nitric Oxide